We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCS icon
1201
Century Communities
CCS
$2.03B
– –
-22,294
Closed -$534K
CDE icon
1202
Coeur Mining
CDE
$17.9B
– –
-60,025
Closed -$245K
CDP icon
1203
COPT Defense Properties
CDP
$4.21B
– –
-103,867
Closed -$2.84M
CE icon
1204
Celanese
CE
$4.82B
– –
-31,744
Closed -$3.13M
CEPU
1205
Central Puerto
CEPU
$2.1B
– –
-93,841
Closed -$862K
CERS icon
1206
Cerus
CERS
$474M
– –
-2,145
Closed -$13K
CF icon
1207
CF Industries
CF
$17.3B
– –
-363,927
Closed -$14.9M
CHDN icon
1208
Churchill Downs
CHDN
$6.12B
– –
-1,560
Closed -$70K
CHCT
1209
Community Healthcare Trust
CHCT
$454M
– –
-200
Closed -$7K
MBAI
1210
Check-Cap
MBAI
$10.9M
– –
-4
Closed –
CHGG icon
1211
Chegg
CHGG
$102M
– –
-2,300
Closed -$88K
CHRD icon
1212
Chord Energy
CHRD
$7.39B
– –
-40,627
Closed -$245K
CIB icon
1213
Grupo Cibest SA
CIB
$21.1B
– –
-890
Closed -$45K
CIG icon
1214
CEMIG Preferred Shares
CIG
$6.01B
– –
-22
Closed –
CIGI icon
1215
Colliers International
CIGI
$5.19B
– –
-5,900
Closed -$394K
CLX icon
1216
Clorox
CLX
$12.7B
– –
-407
Closed -$65K
CM icon
1217
Canadian Imperial Bank of Commerce
CM
$108B
– –
-7,800
Closed -$308K
CMC icon
1218
Commercial Metals
CMC
$8.31B
– –
-20,983
Closed -$358K
CME icon
1219
CME Group
CME
$94.8B
– –
-3,261
Closed -$537K
CMS icon
1220
CMS Energy
CMS
$22.3B
– –
-40,536
Closed -$2.25M
CMTL icon
1221
Comtech Telecommunications
CMTL
$51.8M
– –
-5,397
Closed -$125K
CNC icon
1222
Centene
CNC
$32.5B
– –
-168,969
Closed -$8.97M
CNDT icon
1223
Conduent
CNDT
$264M
– –
-52,713
Closed -$729K
CNO icon
1224
CNO Financial Group
CNO
$5.1B
– –
-36,477
Closed -$590K
CNNE icon
1225
Cannae Holdings
CNNE
$649M
– –
-10,534
Closed -$256K
47 48
49
50 51

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.